Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties
A model-based framework is presented to predict monoclonal antibody (mAb) pharmacokinetics (PK) in humans based on in vitro measures of antibody physiochemical properties. A physiologically based pharmacokinetic (PBPK) model is used to explore the predictive potential of 14 in vitro assays designed...
Saved in:
Main Authors: | Shihao Hu (Author), Amita Datta-Mannan (Author), David Z. D'Argenio (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies
by: Amita Datta-Mannan, et al.
Published: (2020) -
A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data
by: Hannah M. Jones, et al.
Published: (2019) -
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice
by: Shufang Liu, et al.
Published: (2023) -
A Physiologically‐Based Pharmacokinetic Model for the Prediction of "Half‐Life Extension" and "Catch and Release" Monoclonal Antibody Pharmacokinetics
by: Hannah M. Jones, et al.
Published: (2020) -
Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis
by: Karine Rodríguez-Fernández, et al.
Published: (2022)